Teachers Retirement System of The State of Kentucky Has $10.38 Million Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Teachers Retirement System of The State of Kentucky boosted its holdings in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 20.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 49,178 shares of the company's stock after acquiring an additional 8,240 shares during the quarter. Teachers Retirement System of The State of Kentucky owned about 0.16% of Inspire Medical Systems worth $10,379,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of INSP. State Street Corp raised its position in Inspire Medical Systems by 78.0% in the third quarter. State Street Corp now owns 1,049,784 shares of the company's stock worth $221,557,000 after acquiring an additional 459,990 shares in the last quarter. Point72 Asset Management L.P. increased its stake in Inspire Medical Systems by 954.4% in the 3rd quarter. Point72 Asset Management L.P. now owns 319,364 shares of the company's stock worth $67,402,000 after purchasing an additional 289,075 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in Inspire Medical Systems by 798.3% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company's stock worth $56,530,000 after purchasing an additional 238,034 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Inspire Medical Systems by 32.3% in the 2nd quarter. Bank of New York Mellon Corp now owns 787,815 shares of the company's stock worth $105,433,000 after purchasing an additional 192,238 shares in the last quarter. Finally, AQR Capital Management LLC increased its stake in Inspire Medical Systems by 152.7% in the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company's stock worth $31,028,000 after purchasing an additional 140,090 shares in the last quarter. 94.91% of the stock is currently owned by institutional investors.

Inspire Medical Systems Stock Performance

Shares of Inspire Medical Systems stock traded down $2.77 during trading on Thursday, hitting $190.00. 327,936 shares of the stock traded hands, compared to its average volume of 586,828. The stock has a market cap of $5.69 billion, a P/E ratio of 178.43 and a beta of 1.31. Inspire Medical Systems, Inc. has a twelve month low of $123.00 and a twelve month high of $257.40. The company has a fifty day moving average price of $195.14 and a two-hundred day moving average price of $178.27.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.54. The business had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The firm's revenue was up 32.6% on a year-over-year basis. During the same period in the previous year, the company earned ($0.29) EPS. On average, equities research analysts expect that Inspire Medical Systems, Inc. will post 1.33 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on INSP. Robert W. Baird lifted their price target on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an "outperform" rating in a research note on Tuesday, November 5th. Stifel Nicolaus reissued a "hold" rating and issued a $200.00 price target (up previously from $170.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Royal Bank of Canada reissued an "outperform" rating and issued a $260.00 price target on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Piper Sandler reaffirmed an "overweight" rating and set a $260.00 target price (up previously from $255.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Finally, Leerink Partners lifted their target price on Inspire Medical Systems from $167.00 to $197.00 and gave the company a "market perform" rating in a research note on Tuesday, September 10th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, Inspire Medical Systems has an average rating of "Moderate Buy" and a consensus price target of $233.58.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.